TNFSF11 and rheumatoid arthritis: It is plausible, therefore, that the bone-protective effect of TNFαI that we found in our study and that can be seen in women with RA receiving treatment with either ETA or ADA is, at least partially, mediated through the RANKL/OPG pathway.